- Zai Lab is dedicated to incomes your belief by means of our environmental, social, and governance (ESG) technique, which we’re calling Trust for Life
- Zai’s Trust for Life technique contains three commitments to enhance human well being, create higher outcomes, and act proper now
- Zai’s objective is to achieve a million sufferers by 2030
SHANGHAI and CAMBRIDGE, Mass., Oct. 14, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, progressive, commercial-stage, world biopharmaceutical firm, at this time introduced the launch of its 2022 Trust Report.
“Zai Lab recognizes the importance of building and maintaining trust for life from the various stakeholders we serve, including patients, employees, healthcare professionals, communities, and investors,” stated Jim Massey, Chief Sustainability Officer for Zai Lab. “We seek to earn that trust, in part, through our ESG strategy and our commitment to improve human health, create better outcomes, and act right now.”
Through this report, Zai seeks to additional clarify our Trust for Life technique, commitments, actions, and targets. In abstract, we search to:
- Improve Human Health. Zai’s mission is to find, develop, and commercialize medicines that assist tackle vital unmet wants of sufferers with critical illnesses. This is what motivates all that Zai does, together with its continued analysis and growth and collaborations with different main biopharmaceutical corporations to speed up entry to remedies that enhance human well being.
Target: Reach a million sufferers by 2030.
- Create Better Outcomes. Zai is concentrated on delivering higher outcomes for sufferers in addition to its workers and the communities it serves. To this finish, Zai is dedicated to variety, fairness, and inclusion, together with in its workforce. Regarding gender variety, ladies make up 58% of Zai workers, together with 53% of all STEM-related positions. Proudly, Zai has achieved base pay fairness in any respect ranges. Zai can also be dedicated to doing our half to guard our planet. As Zai continues to develop globally, it commits to an environmental technique that’s planet optimistic with a goal of internet zero greenhouse gasoline emissions.
Target: Maintain gender fairness in management and base pay.
- Act Right Now. Because each minute counts for sufferers going through the challenges of great illnesses and restricted therapy choices, Zai is dedicated to appearing urgently and ethically, with robust company governance and danger administration practices.
Target: Complete Enterprise Risk Management (ERM) top-tier mitigation plans yearly.
Zai’s strategy is aligned with the United Nations Sustainable Development Goals, and in September 2022, the S&P Global Corporate Sustainability Assessment acknowledged Zai’s sustainability efforts with a rating of 41, up 27 factors from the corporate’s 2021 score. Zai’s 2022 score is according to the efficiency of a lot bigger biotech corporations.
“I’m really proud of the entire Zai Lab team for their commitment to earning trust every day through all they do,” stated Josh Smiley, Chief Operating Officer, Zai Lab. “We recognize that many people may count on one or more Zai medicines for long-term benefits, and we want to make sure we build and maintain their trust for a lifetime.”
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an progressive, research-based, commercial-stage biopharmaceutical firm primarily based in China and the United States targeted on bringing transformative medicines for oncology, autoimmune issues, infectious illnesses, and neurological issues to sufferers in China and all over the world. Our objective is to leverage our competencies and assets to positively influence human well being worldwide.
For extra details about Zai Lab, together with our merchandise, business actions and partnerships, analysis, and different occasions or developments, please go to www.zailaboratory.com and observe us at www.twitter.com/ZaiLab_Global.
Zai Lab Forward-Looking Statements
This press launch comprises forward-looking statements regarding Zai Lab’s future expectations, plans, and prospects, together with, with out limitation, statements relating to our means to advance our medical pipeline and additional display our industrial and discovery capabilities and anticipated milestones for our merchandise and product candidates. All statements, aside from statements of historic reality, included on this press launch are forward-looking statements and will be recognized by phrases reminiscent of “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “plan,” “possible,” “potential,” “will,” “would,” and different related expressions. Such statements represent forward-looking statements throughout the which means of the Private Securities Litigation Reform Act of 1995. Forward-looking statements usually are not ensures or assurances of future efficiency. Forward-looking statements are primarily based on our expectations and assumptions as of the date of this press launch and are topic to inherent uncertainties, dangers, and modifications in circumstances that will differ materially from these contemplated by the forward-looking statements. We might not truly obtain the plans, perform the intentions, or meet the expectations or projections disclosed in our forward-looking statements, and you shouldn’t place undue reliance on these forward-looking statements. Actual outcomes might differ materially from these indicated by forward-looking statements because of varied vital components, together with however not restricted to (1) our means to efficiently commercialize and generate income from our accredited merchandise, (2) our means to acquire funding for our operations and business initiatives, (3) the outcomes of our medical and pre-clinical growth of our product candidates, (4) the content material and timing of choices made by the related regulatory authorities relating to regulatory approvals of our product candidates, (5) the consequences of the novel coronavirus (COVID-19) pandemic, together with any authorities actions or lockdown measures taken in response, on our business and basic financial, regulatory, and political circumstances, (6) dangers associated to doing business in China, and (7) different components recognized in our most up-to-date annual and quarterly stories and in different stories now we have filed with the U.S. Securities and Exchange Commission. We anticipate that subsequent occasions and developments will trigger our expectations and assumptions to vary, and we undertake no obligation to replace or revise any forward-looking statements, whether or not because of new data, future occasions, or in any other case, besides as could also be required by legislation. These forward-looking statements shouldn’t be relied upon as representing our views as of any date subsequent to the date of this press launch.
Our SEC filings will be discovered on our web site at www.zailaboratory.com and on the SEC’s web site at www.sec.gov.
For extra data, please contact:
Media: Christine Drury / Xiaoyu Chen
[email protected] /[email protected]
+1 (317) 385-9227 / +86 185 0015 5011
Investor Relations: Lina Zhang
[email protected]
+86 136 8257 6943
Source: Zai Lab Limited
